Skip to main content

Gordon Carl L's Form 4 filing

Adicet Bio, Inc.ACET · filed Jan 26, 2024

Accession no.
0000950170-24-008052
Filed
Jan 26, 2024
Trade date
Jan 25, 2024
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions. Open-market purchases total $7.50M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Gordon Carl LCIK 0001282930Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 25, 2024Common StockPPurchaseAcquired+1,841,100$2.40+$4,418,6407,526,359Indirect
Jan 25, 2024Common StockPPurchaseAcquired+242,200$2.40+$581,280990,254Indirect
Jan 25, 2024Common StockPPurchaseAcquired+1,041,700$2.40+$2,500,0801,255,985Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)